Nitesh Yadav

Mr. Nitesh Yadav

Student
+1

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
Iara BaldimIara Baldim
Iara Baldim
WOWanderley Pereira Oliveira
Wanderley Pereira Oliveira
VKVarsha Kadian
Varsha Kadian
RRRekha Rao
Rekha Rao
NYNitesh Yadav
Nitesh Yadav
Eliana B. SoutoEliana B. Souto
Eliana B. Souto
Several pharmacological properties are attributed to ergot alkaloids as a result of their antibacterial, antiproliferative, and antioxidant effects. Although known for their biomedical applications (e.g., for the treatment of glaucoma), most ergot alkaloids exhibit high toxicological risk and may even be lethal to humans and animals. Their pharmacological profile results from the structural similarity between lysergic acid-derived compounds and noradrenalin, dopamine, and serotonin neurotransmitters. To reduce their toxicological risk, while increasing their bioavailability, improved delivery systems were proposed. This review discusses the safety aspects of using ergot alkaloids in ocular pharmacology and proposes the development of lipid and polymeric nanoparticles for the topical administration of these drugs to enhance their therapeutic efficacy for the treatment of glaucoma.